Patient Benefit
Patient Benefit
Welcome to CellVec
Vectors for translational and commercial gene therapies
CellVec is a certified GMP gene therapy Contract Development and Manufacturing Organisation (CDMO) that is a specialist provider of custom viral vectors for pre-clinical and clinical applications.
With the use of our lentivirus-based CellVec Vector Platform, we set ourselves apart through the ability to overcome current technological bottlenecks in the upscale production of viral vectors and develop novel gene transfer technologies for advanced therapies in order to facilitate the advancement of our client’s products from bench-to-bedside for clinical applications.
Watch Video
Our Story
Capabilities Overview
Quality in Everything We Do
Quality in Everything
We Do
Regulatory and Quality
Technology Platform
Manufacturing
Innovation
Facility
Services Overview
Bespoke Services for Every Need
Process Development
Manufacturing
Regulatory & Quality Assurance
Quality Control & Characterisation
Project Management
Our Facility
CellVec’s state-of-the-art GMP manufacturing facility, constructed based on the principles of the PIC/S GMP guide, Eudralex Vol. 4 and relevant annexes, encompasses the process-driven design approach that we adopt for the manufacture of viral vectors for gene therapy and other cellular ATMPs. Our GMP production Clean room facility is constructed to accommodate flexible Viral Vector production runs, where we focus on a single product at a time, on a campaign basis.
BSL2 facility design
Grade A production environment
Validated Environmental Monitoring System (EMS)
Controlled personnel and material access
